logo
episode-header-image
Dec 2022
40m 20s

PARP Inhibitors in Advanced Prostate Can...

AMERICAN UROLOGICAL ASSOCIATION
About this episode
PARP Inhibitors in Advanced Prostate Cancer Care Podcast CME Available: https://auau.auanet.org/node/37321 Host: Jay D. Raman, MD, FACS Guests: Maha Hussain, MD and Ganesh Raj, MD, PhD LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Identify approved PARP Inhibitors for prostate cancer and patients who may benefit ... Show More
Up next
Nov 19
Core Curriculum: Surgical Management of Urolithiasis
Core Curriculum: Surgical Management of Urolithiasis AUA Urology Core Curriculum: auau.auanet.org/core Host: Mark L. Gonzalgo, MD, PhD, MBA Guests: Marcelino E. Rivera, MD and T. Max Shelton, MD Outline: Segment 1: Acute Stone Event and Radiographic Evaluation Segment 2: Shock ... Show More
36m 39s
Nov 12
AUA2025: Key Takeaways: BPH
AUA2025: Key Takeaways: BPH Presenters: Bilal Chughtai, MD & Dean S. Elterman, MD, MSc, FRCSC 
22m 28s
Nov 5
AUA2025: Key Takeaways: Lower Urinary Tract Reconstruction
AUA2025: Key Takeaways: Lower Urinary Tract Reconstruction Presenters: George E. Koch, MD & Kurt A. McCammon, MD, FACS 
22m 44s
Recommended Episodes
Oct 2024
Quality of life for mPCa patients undergoing treatment
<p>In this interview recorded at UROonco24 in Budapest earlier in the year, Dr. Gianluca Giannarini (IT) talks with Prof. Geert De Meerleer (BE) about the quality of life for patients with metastatic prostate cancer (mPCa) that are undergoing treatment. Their conversation feature ... Show More
10m 26s
May 2023
AUANewsWorthy Webinar: An Integrated Biomarker and MRI Risk Assessment Approach to Prostate Cancer Diagnosis
Prostate cancer diagnostic guidelines aim to minimize over-diagnosis of clinically insignificant prostate cancer (Gleason6/GG1). The clinical question before us is how do we enable the best balance, helping to increase compliance with the biopsy recommendation for patients at hig ... Show More
51m 37s
Jul 2024
#310 - The relationship between testosterone and prostate cancer, testosterone replacement therapy, and tools for predicting cancer aggressiveness and guiding therapy | Ted Schaeffer, M.D., Ph.D.
<p><a href= "https://peterattiamd.com/TedSchaeffer3/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=240722-pod-TedSchaeffer3&utm_content=240722-pod-TedSchaeffer3-podfeed"> View the Show Notes Page for This Episode</a></p> <p><a href= "https://peterattiamd.com/subscribe/ ... Show More
47m 53s
Feb 2023
206. #PROSTATE PRISE EN CHARGE DES FISTULES URÉTRO-RECTALES APRÈS UN CANCER DE LA PROSTATE LOCALISÉ - DOCTEUR PAUL NEUVILLE
206. #PROSTATE PRISE EN CHARGE DES FISTULES URÉTRO-RECTALES APRÈS UN CANCER DE LA PROSTATE LOCALISÉ - DOCTEUR PAUL NEUVILLELa fistule urétro-rectale après prostatectomie appartient-elle au passé ?Peut-on réaliser un traitement conservateur et comment ?Quelle prise en charge chiru ... Show More
6m 37s
Jul 2024
18F-PSMA-1007 PET/CT - sponsored by Mayo Clinic
Dr. Ashwin Singh Parihar discusses the role of multiparametric MRI and 18F-PSMA-1007 PET/CT for the detection of clinically significant prostate cancer with Dr. Bastiaan Privé. This episode is sponsored by Mayo Clinic. Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detectio ... Show More
18m 6s
Nov 2022
197. #PROSTATE COMMENT MIEUX PRENDRE EN CHARGE LA QUALITÉ DE VIE D'UN PATIENT TRAITÉ PAR HORMONOTHÉRAPIE POUR UN CANCER DE LA PROSTATE ? - DOCTEUR JONATHAN OLIVIER
Comment mieux prendre en charge la qualité de vie d'un patient traité par hormonothérapie pour un cancer de prostate ?Quelles sont les effets indésirables de l’hormonothérapie ?Comment prendre en charge les risques de complication cardiovasculaire et les risques d’osthéoporose ?C ... Show More
6m 49s
Sep 2024
ESMO 2024 special: Results of interim analysis of SunRISe-4
<p>UROONCO BCa chief editor Dr. Benjamin Pradere talks to Assoc. Prof. Andrea Necchi (IT) at EMSO 2024 on the results of the interim analysis of SunRISe-4 study: TAR-200 plus cetrelimab or CET alone as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are in ... Show More
10m 22s
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
56m 23s
Oct 2024
393. SGLT Inhibitors: Clinical Implementation of SGLT Inhibitors with Dr. Alison Bailey
CardioNerds Drs. Jason Feinman, Gurleen Kaur, and Rick Ferraro discuss the implementation of SGLT inhibitors in clinical practice with Dr. Alison Bailey. Notes were drafted by Dr. Jason Feinman. In this episode, we discuss the implementation of SGLTi in clinical practice scena ... Show More
19m 21s
Jul 2024
382. SGLT Inhibitors: The Data Supporting SGLT Inhibition with Dr. Muthiah Vaduganathan
CardioNerds Dr. Rick Ferraro, Dr. Gurleen Kaur, and Dr. Maryam Barkhordarian discuss the evidence and data supporting SGLT inhibition for cardiovascular and kidney health outcomes with expert faculty Dr. Muthu Vaduganathan. They discuss the role of SGLT inhibitors in different po ... Show More
24m 23s
Listen to millions of songs and podcasts on Anghami